Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
189.19B | 208.35B | 241.39B | 157.74B | 105.94B | Gross Profit |
30.24B | 64.06B | 55.10B | 22.86B | 10.18B | EBIT |
12.85B | 46.98B | 44.76B | 15.09B | -346.00M | EBITDA |
27.98B | 43.50B | 59.47B | 32.55B | 14.54B | Net Income Common Stockholders |
381.00M | 15.24B | -2.49B | 7.57B | -20.30B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
34.52B | 28.59B | 29.77B | 30.96B | 29.53B | Total Assets |
282.23B | 280.29B | 288.12B | 287.27B | 267.65B | Total Debt |
71.55B | 63.08B | 55.49B | 69.79B | 81.93B | Net Debt |
32.34B | 35.33B | 26.30B | 39.11B | 52.73B | Total Liabilities |
203.91B | 194.80B | 205.13B | 196.83B | 182.09B | Stockholders Equity |
59.25B | 70.28B | 67.55B | 75.46B | 71.25B |
Cash Flow | Free Cash Flow | |||
12.00B | 17.75B | 28.86B | 12.72B | -144.00M | Operating Cash Flow |
27.30B | 32.04B | 40.93B | 23.61B | 12.16B | Investing Cash Flow |
-13.25B | -14.87B | -13.71B | -5.69B | -7.86B | Financing Cash Flow |
-7.30B | -13.36B | -28.02B | -18.08B | 3.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | £148.03B | 14.52 | 7.41% | 4.34% | -4.09% | -20.79% | |
73 Outperform | £236.35M | 3.33 | 18.48% | ― | -21.23% | ― | |
71 Outperform | £55.45B | ― | 0.64% | ― | ― | ― | |
61 Neutral | £191.96M | 4.18 | ― | -11.70% | ― | ||
61 Neutral | £2.66B | 21.62 | -2.87% | 12.53% | 29.33% | ― | |
56 Neutral | $6.93B | 3.42 | -4.86% | 5.94% | -0.08% | -48.18% | |
51 Neutral | £159.98M | 17.20 | -3.25% | ― | -28.38% | 90.60% |